4.8 • 8.2K Ratings
🗓️ 8 April 2025
⏱️ 50 minutes
🧾️ Download transcript
Click on a timestamp to play from that location
0:00.0 | In you go. |
0:03.0 | Here you go. |
0:04.0 | It is |
0:20.0 | Tuesday, April 8th, 2025. |
0:22.6 | And what a better way to start your day with a little talk of inflammation. |
0:28.6 | Who doesn't get inflammation? |
0:31.6 | Either here, there, or everywhere. |
0:33.6 | Blake Snell. |
0:35.6 | Hi, my name's David. |
0:46.5 | We're good now here in Miami, talking about inflammation of the throat nodules with a little extra phlegm. |
0:54.0 | Blake Snell, Dodgers, $182 million contract. All off season, we talked about the signings the Dodgers' $182 million contract. |
1:00.6 | All offseason, we talked about the signings the Dodgers were making, the depth that they were acquiring, the fact that they wanted not just a starting five, they wanted a starting |
1:07.1 | 10. |
1:08.2 | And the reason they wanted a starting 10 is that they knew that there were going to be |
1:13.3 | injuries. Why? Because they had pitchers who had never been able to be healthy. And while you can |
1:20.8 | dream the dream that health will come or health will stay, at the end of the day, you realize you were simply deluding yourself. |
1:30.3 | Blake Snell woke up and said, |
1:32.3 | hmm, I feel some inflammation in my shoulder. |
1:36.3 | The Dodgers did their best white snake imitation |
1:39.3 | and said, here we go again on our own. |
1:45.0 | Blake Snell ends up seeing the doctor in DC |
1:48.3 | where the team is playing the nationals. |
... |
Transcript will be available on the free plan in 5 days. Upgrade to see the full transcript now.
Disclaimer: The podcast and artwork embedded on this page are from Dan Le Batard, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Dan Le Batard and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.